Covid-19 vaccine-maker BioNTech to acquire former rival CureVac
Both German companies have continued mRNA programs on so-called cancer vaccines.
You are not logged in so some information on this page has been withheld. To see more, please log in.
BioNTech
since
auto-detected in 63 stories
5 days ago
15 days ago
Stocks making the biggest moves midday: Tesla, BioNTech, DraftKings, Steel Dynamics and more
These are some of the stocks posting the largest moves in midday trading.
3 months ago
This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says
BioNTech has a promising cancer treatment pipeline, per Citi.
4 months ago
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
found
Shares of Moderna, BioNTech, Novavax, GSK and Pfizer fell on Tuesday following the vote.
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
found
Shares of Moderna, BioNTech, Novavax, GSK and Pfizer fell on Tuesday following the vote.
6 months ago
BioNTech’s boss, Ugur Sahin, remains sanguine about Omicron
Its vaccine may need a tweak, but most important is to speed up booster shots
page 1 of 1